NCT07615790 Structured Combined Exercise Program in Postmenopausal Women: Effects on Heart Rate Variability and Menopausal Symptoms
| NCT ID | NCT07615790 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fenerbahce University |
| Condition | Postmenopausal |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2026-04-27 |
| Primary Completion | 2026-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2026-04-27 with a primary completion date of 2026-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn whether a structured combined exercise program can improve heart health, menopausal symptoms, sleep quality, and quality of life in postmenopausal women aged 45 to 65 years. The main questions it aims to answer are: Does the exercise program improve heart rate variability, which shows how well the heart is controlled by the nervous system? Does the exercise program lower menopausal symptoms? Does the exercise program improve sleep quality and quality of life? Researchers will compare women who join the exercise program with women who continue their usual daily activities. Participants in the exercise group will take part in a supervised exercise program for 12 weeks. They will exercise 2 days each week. Each session will last 45 minutes and will include warm-up, balance, strengthening, coordination, flexibility, and cool-down exercises. Participants in the control group will continue their usual daily activities during the study.
Eligibility Criteria
Inclusion Criteria: * Women in the postmenopausal period * Aged between 45 and 65 years * Able to communicate and cooperate with the researchers * Not participating in another structured exercise program * Willing to participate voluntarily in the study Exclusion Criteria: * Presence of severe cardiovascular, neurological, orthopedic, or psychiatric disease * Hormone replacement therapy use during the study period * Cognitive impairment affecting participation * Uncontrolled hypertension or other unstable medical conditions * Regular participation in structured exercise training within the last 6 months * Smoking or alcohol use that may affect heart rate variability measurements
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07615790 clinical trial?
This trial is open to female participants only, aged 45 Years or older, up to 65 Years, studying Postmenopausal. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07615790 currently recruiting?
Yes, NCT07615790 is actively recruiting participants. Contact the research team at burcu.akkurt@fbu.edu.tr for enrollment information.
Where is the NCT07615790 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT07615790 clinical trial?
NCT07615790 is sponsored by Fenerbahce University. The trial plans to enroll 40 participants.